Do you have any recommendations for domestic manufacturers to switch to domestic antibodies for Western blot?

Mouse tissue samples themselves have high background. When selecting domestic primary antibodies, focus on whether the species reactivity explicitly includes mouse, and it is best if the manufacturer has tissue WB validation images. For loading control antibodies such as GAPDH and β-actin, domestic replacements can be prioritized because the risk is relatively low. For phosphorylated or modified antibodies, batch-to-batch variation may be more pronounced. It is recommended to first validate expression using total protein antibodies, then use phosphorylated antibodies, and use the same fixed lot for multiple replicates. If performing quantitative or semi-quantitative WB, it is also necessary to verify that the signal is within the linear range. The sensitivity of domestic antibodies may be slightly lower than that of imported ones, so exposure time may need to be adjusted. In summary, domestic substitution is feasible, but 1-2 weeks should be reserved for validation, and critical experiments should not be directly placed on unvalidated lots.

I suggest not looking at the "ranking" of domestic antibodies for now, but rather searching literature and user feedback by target. Novizan, Yiqiao Shenzhou, and Zhengneng have all been used. The WB antibodies of Novizan and Yiqiao have relatively stable overall quality control, and the Zhengneng targets have high cost-effectiveness. Batch differences have improved among top manufacturers in recent years, but WB primary antibody still recommends conducting small sample validation after arrival, especially for mouse tissue samples with high background. You can first buy small packages or apply for a trial, run the same batch of protein, and compare it with imported antibodies in parallel to see the target band position, signal-to-noise ratio, and background. The price ranges from 800 to 1500 per unit, covering most conventional targets, and phosphorylated antibodies may be slightly higher. The spot rate of these suppliers is decent, and the after-sales technical support response is also fast.

Explain the application and sample types clearly before sales, and confirm that the manufacturer has WB data instead of just IHC/IF. Clarify the return and exchange conditions for invalid or high background items, whether there is no signal for exchange, and whether high background items can be returned to avoid disputes after payment. Cold or ice pack transportation is required for supply, and temperature records should be kept, especially in summer. Batch ordering can be negotiated with sales to lock in batches and reserve inventory, ensuring at least 3-6 months of same batch. The technical support of Nuoweizan and Yiqiao generally requires samples and experimental conditions, and the response is fast; Positive customer service channels are also possible, but some niche targets need to wait for stock adjustment. It is best to have email or work order records for after-sales service to facilitate traceability in the future.

Don't replace all antibodies with domestic ones at once. It is recommended to first select 1-2 key targets for replacement validation. After arrival, check the COA and lot number first, and clarify whether WB applications, recommended dilution, and species reactivity are guaranteed. Run with known positive and negative samples, and perform a primary antibody concentration gradient, such as 1:500, 1:1000, 1:2000, to compare band intensity and background. Differences between domestic antibody lots may be reflected in nonspecific bands and background, so a new lot for the same target must be run again, and the old lot should be kept as a control. After validation is satisfactory, gradually replace other antibodies, and fix the procurement channel and lot to avoid incomparable data caused by changing lots midway.